Items 1 to 10 of about 714504
1. Pärna K, Põld M, Ringmets I: Physicians' views on the role of smoking in smoking-related diseases: findings from cross-sectional studies from 1982-2014 in Estonia. Tob Induc Dis; 2017;15:31
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Physicians' views on the role of smoking in smoking-related diseases: findings from cross-sectional studies from 1982-2014 in Estonia.
  • METHODS: Cross-sectional postal surveys were sent to all practising physicians in Estonia in 1982, 2002 and 2014 providing data from 3504, 2694, and 2865 physicians respectively.
  • RESULTS: The age-standardized prevalence of current smoking among men decreased from 39.6% in 1982 to 14.2% in 2014, and among women from 12.4 to 5.1%, respectively.
  • Compared with 1982, the proportion of physicians agreeing with statements that smoking is a major cause or one of the causes of IHD, lung cancer, or chronic bronchitis was significantly higher in 2002 and 2014.
  • CONCLUSION: From 1982 to 2014, physicians' attitudes towards the health risks of smoking improved in Estonia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Public Health. 2007 Jun 20;7:115 [17578582.001]
  • [Cites] Tob Induc Dis. 2008 Dec 29;4:13 [19114012.001]
  • [Cites] Int J Environ Res Public Health. 2013 Dec 30;11(1):429-55 [24380976.001]
  • [Cites] J Epidemiol. 2013;23(1):4-11 [23149752.001]
  • [Cites] Scand J Public Health. 2002;30(2):133-40 [12028862.001]
  • [Cites] Health Serv Res. 2001 Feb;35(6):1347-55 [11221823.001]
  • [Cites] Tob Induc Dis. 2008 Sep 09;4:9 [18822167.001]
  • [Cites] Scand J Public Health. 2003;31(2):149-55 [12745766.001]
  • [Cites] Can J Public Health. 2010 Jul-Aug;101(4):290-3 [21033533.001]
  • [Cites] BMJ. 1994 Oct 8;309(6959):901-11 [7755693.001]
  • [Cites] Eur J Public Health. 2004 Jun;14(2):201-3 [15230511.001]
  • [Cites] Patient Educ Couns. 2009 Jan;74(1):118-23 [18774670.001]
  • [Cites] BMC Health Serv Res. 2009 Sep 14;9:160 [19751504.001]
  • [Cites] Public Health. 2005 May;119(5):390-9 [15780327.001]
  • [Cites] Soz Praventivmed. 2005;50(6):378-88 [16398100.001]
  • [Cites] J Subst Abuse. 1990;2(2):201-15 [2136110.001]
  • (PMID = 28814949.001).
  • [ISSN] 2070-7266
  • [Journal-full-title] Tobacco induced diseases
  • [ISO-abbreviation] Tob Induc Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Attitudes / Estonia / Knowledge / Physicians / Smoking / Smoking-related disease
  •  go-up   go-down


2. QuickStats: Percentage* of Children and Teens Aged 6-17 Years Who Missed >10 Days of School in the Past 12 Months Because of Illness or Injury,<sup>†</sup> by Serious Emotional or Behavioral Difficulties Status<sup>§</sup> and Age Group - National Health Interview Survey, 2014-2016<sup>¶</sup>. MMWR Morb Mortal Wkly Rep; 2017 Nov 10;66(44):1239
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] QuickStats: Percentage* of Children and Teens Aged 6-17 Years Who Missed >10 Days of School in the Past 12 Months Because of Illness or Injury,<sup>†</sup> by Serious Emotional or Behavioral Difficulties Status<sup>§</sup> and Age Group - National Health Interview Survey, 2014-2016<sup>¶</sup>.
  • During 2014-2016, children aged 6-17 years whose parent or guardian indicated the child had serious emotional or behavioral difficulties (EBDs) were almost four times as likely to miss >10 days of school because of illness or injury compared with children without serious EBDs (13.4% compared with 3.5%).
  • Among children with serious EBDs, those aged 6-10 years were less likely (8.0%) to miss >10 days of school compared with children aged 11-14 years (15.6%) and children aged 15-17 years (19.5%).
  • Among children without serious EBDs those aged 15-17 years (4.7%) were more likely to miss >10 school days compared with children aged 6-10 years (3.0%) and children aged 11-14 years (3.3%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29120998.001).
  • [ISSN] 1545-861X
  • [Journal-full-title] MMWR. Morbidity and mortality weekly report
  • [ISO-abbreviation] MMWR Morb. Mortal. Wkly. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. Shannon FQ 2nd, Horace-Kwemi E, Najjemba R, Owiti P, Edwards J, Shringarpure K, Bhat P, Kateh FN: Effects of the 2014 Ebola outbreak on antenatal care and delivery outcomes in Liberia: a nationwide analysis. Public Health Action; 2017 Jun 21;7(Suppl 1):S88-S93

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effects of the 2014 Ebola outbreak on antenatal care and delivery outcomes in Liberia: a nationwide analysis.
  • <b>Objectives:</b> To determine access to antenatal care (ANC), deliveries and their outcomes before, during and after the 2014-2015 Ebola outbreak.
  • <b>Objectif :</b> Déterminer l'accès aux consultations prénatales (ANC), aux accouchements assistés et à leurs résultats avant, pendant et après l'épidémie d'Ebola de 2014 à 2015.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Med. 2016 Aug 02;13(8):e1002096 [27482706.001]
  • [Cites] Public Health Action. 2012 Mar 21;2(1):21-2 [26392940.001]
  • [Cites] Lancet. 2014 Dec 13;384(9960):2105 [25497191.001]
  • [Cites] PLoS Med. 2010 Aug 10;7(8):null [20711476.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Jan 2;63(51):1226-7 [25551595.001]
  • [Cites] PLoS Curr. 2015 Aug 04;7:null [26331094.001]
  • [Cites] BMC Int Health Hum Rights. 2011 Mar 09;11 Suppl 1:S11 [21410998.001]
  • [Cites] Lancet. 2007 Oct 20;370(9596):1453-7 [18064739.001]
  • [Cites] Ethiop J Health Sci. 2014 Sep;24 Suppl:93-104 [25489186.001]
  • [Cites] BMC Pregnancy Childbirth. 2015 Oct 12;15:254 [26459295.001]
  • [Cites] Indian J Community Med. 2009 Jan;34(1):15-8 [19876449.001]
  • [Cites] Int J Tuberc Lung Dis. 2015 Nov;19(11):1271-5 [26467577.001]
  • [Cites] PLoS One. 2016 Aug 17;11(8):e0157296 [27533499.001]
  • (PMID = 28744445.001).
  • [ISSN] 2220-8372
  • [Journal-full-title] Public health action
  • [ISO-abbreviation] Public Health Action
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  • [Keywords] NOTNLM ; ANC / SORT IT / caesarian section / delivery outcomes / operational research
  •  go-up   go-down


4. Shams-Beyranvand M, Farzadfar F, Naderimagham S, Tirani M, Maracy MR: Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models. J Diabetes Metab Disord; 2017;16:12
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Estimation of burden of ischemic heart diseases in Isfahan, Iran, 2014: using incompleteness and misclassification adjustment models.
  • METHODS: This population-based study was conducted on the population living in the city of Isfahan in 2014.
  • Years of life lost due to premature mortality (YLLs) were calculated by multiplying the number of deaths due to IHDs (that was collected from death registration system (DRS) and was adjusted for incompleteness and misclassification) with life expectancy (that was extracted from the Global Burden of Diseases, Injuries, and Risk Factors study (GBD) 2013).
  • Years lived with disability (YLDs) were calculated by multiplying the prevalent cases of IHDs in each age-sex group (that was calculated using the stepwise approach to non-communicable disease risk factor surveillance (STEPS)) with total disability weight of IHDs (that was calculated using the GBD 2013).
  • RESULTS: In 2014, the number of DALYs due to IHDs was 43517.71 years which was formed of 31891.79 years of YLLs and 11625.92 years of YLDs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Res Med Sci. 2015 Nov;20(11):1077-83 [26941812.001]
  • [Cites] Int J Epidemiol. 2010 Apr;39 Suppl 1:i7-10 [20348129.001]
  • [Cites] Lancet. 2015 Jan 10;385(9963):117-71 [25530442.001]
  • [Cites] PLoS Med. 2010 Apr 13;7(4):e1000262 [20405002.001]
  • [Cites] Glob Heart. 2014 Mar;9(1):91-9 [24977114.001]
  • [Cites] Neuroepidemiology. 2015 ;45(3):203-14 [26505984.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2197-223 [23245608.001]
  • [Cites] Arch Iran Med. 2014 May;17(5):304-20 [24784860.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2095-128 [23245604.001]
  • [Cites] Can J Cardiol. 2015 Sep;31(9):1151-9 [26321437.001]
  • [Cites] Int J Prev Med. 2016 Jul 29;7:96 [27563432.001]
  • [Cites] Int J Cardiol. 2016 Jul 1;214:265-9 [27077547.001]
  • [Cites] Arch Iran Med. 2014 Jan;17(1):7-15 [24444059.001]
  • [Cites] Am J Public Health. 2016 Jan;106(1):74-8 [26696288.001]
  • [Cites] HIM J. 2014;43(2):35-42 [24948664.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2063-6 [23245602.001]
  • [Cites] Lancet. 2015 Aug 22;386(9995):743-800 [26063472.001]
  • [Cites] Glob J Health Sci. 2012 Dec 21;5(2):134-44 [23445701.001]
  • [Cites] Bull World Health Organ. 2011 Feb 1;89(2):112-20 [21346922.001]
  • [Cites] Rev Esp Cardiol (Engl Ed). 2015 Nov;68(11):968-75 [25887346.001]
  • [Cites] Diabetes Res Clin Pract. 2014 Feb;103(2):319-27 [24447808.001]
  • (PMID = 28331842.001).
  • [ISSN] 2251-6581
  • [Journal-full-title] Journal of diabetes and metabolic disorders
  • [ISO-abbreviation] J Diabetes Metab Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Burden of disease / Disability-adjusted life years (DALYs) / Ischemic heart diseases (IHDs) / Years lived with disability (YLDs) / Years of life lost due to premature mortality (YLLs)
  •  go-up   go-down


5. Squire SB: CAHRD Consultation 2014: the 10-20 year Horizon Introduction and Overview - as circulated to Consultation participants. BMC Proc; 2015;9(Suppl 10):S2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CAHRD Consultation 2014: the 10-20 year Horizon Introduction and Overview - as circulated to Consultation participants.
  • The overall aim of the 2014 Consultation is to bring together internal and external partners to help shape the strategic direction for CAHRD over the 10 to 20 year horizon.
  • The major challenges that will need to be addressed over the next 10 to 20 years will be scoped and pathways to possible solutions proposed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Adolesc Health. 2013 May;52(5):517-22 [23608717.001]
  • [Cites] PLoS One. 2013 May 27;8(5):e63174 [23723975.001]
  • [Cites] PLoS Med. 2010 Jan 26;7(1):e1000221 [20126256.001]
  • [Cites] Int J Tuberc Lung Dis. 2011 Aug;15(8):996-1004 [21740663.001]
  • [Cites] Health Care Manag Sci. 2012 Sep;15(3):239-53 [22674467.001]
  • [Cites] PLoS Med. 2010 Nov 16;7(11):e1001000 [21124816.001]
  • [Cites] JAMA. 2013 Feb 13;309(6):594-604 [23403684.001]
  • [Cites] J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):577-83 [23337363.001]
  • [Cites] PLoS Med. 2011 Jul;8(7):e1000443 [21765808.001]
  • [Cites] PLoS Med. 2013;10(7):e1001488 [23935459.001]
  • [Cites] J Int AIDS Soc. 2010 Aug 23;13:32 [20731835.001]
  • [Cites] Cochrane Database Syst Rev. 2012 Nov 14;11:CD000371 [23152203.001]
  • [Cites] Lancet Infect Dis. 2011 Mar;11(3):190-207 [21273130.001]
  • [Cites] PLoS One. 2014 Apr 04;9(4):e93083 [24705381.001]
  • [Cites] J Adolesc Health. 2011 Jan;48(1):79-86 [21185528.001]
  • [Cites] PLoS One. 2013 Nov 19;8(11):e79726 [24260293.001]
  • [Cites] N Engl J Med. 2011 Aug 11;365(6):493-505 [21767103.001]
  • [Cites] Health Res Policy Syst. 2014 Apr 17;12:19 [24739525.001]
  • [Cites] BMJ. 2001 Jul 14;323(7304):81-5 [11451782.001]
  • [Cites] AIDS Care. 2006 May;18(4):311-22 [16809108.001]
  • [Cites] Health Policy Plan. 2015 Mar;30(2):181-6 [24463334.001]
  • [Cites] Lancet. 2004 Jan 3;363(9402):9-17 [14723987.001]
  • [Cites] Health Res Policy Syst. 2010 May 13;8:12 [20465809.001]
  • [Cites] Reprod Health. 2014 Jan 02;11(1):1 [24383405.001]
  • [Cites] Health Educ Res. 2010 Dec;25(6):903-16 [20670997.001]
  • [Cites] Cochrane Database Syst Rev. 2013 Jun 27;(6):CD009987 [23807693.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(9):e1806 [22970333.001]
  • [Cites] Lancet Infect Dis. 2013 Dec;13(12):1029-42 [24054085.001]
  • [Cites] PLoS One. 2012;7(9):e39746 [22962575.001]
  • (PMID = 28281700.001).
  • [Journal-full-title] BMC proceedings
  • [ISO-abbreviation] BMC Proc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


6. Biswas T, Uddin MJ, Mamun AA, Pervin S, P Garnett S: Increasing prevalence of overweight and obesity in Bangladeshi women of reproductive age: Findings from 2004 to 2014. PLoS One; 2017;12(7):e0181080
MedlinePlus Health Information. consumer health - Obesity.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increasing prevalence of overweight and obesity in Bangladeshi women of reproductive age: Findings from 2004 to 2014.
  • The objective of this study was to examine the trend of overweight and obesity among Bangladeshi women of reproductive age between 2004 and 2014.
  • METHOD: This is a secondary data analysis of the 2004, 2007, 2011 and 2014 Bangladesh Demographic and Health Surveys (BDHS).
  • RESULT: The prevalence of overweight increased from 11.4% [95% CI: 10.4to 12.5] in 2004 to 25.2% [95% CI: 24.0 to 26.4] in 2014.
  • The prevalence of obesity increased from 3.5% [95% CI: 3.0to4.2] to 11.2% [95% CI: 10.1to12.5%] over the same period of time.
  • The highest prevalence of overweight and obesity were observed in those women with the highest education level and wealth, larger family size, living in urban areas and not being in paid employment.
  • [MeSH-minor] Adolescent. Adult. Age Factors. Bangladesh / epidemiology. Body Weight / physiology. Female. Health Surveys. Humans. Middle Aged. Prevalence. Socioeconomic Factors. Young Adult

  • Genetic Alliance. consumer health - Obesity.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS One. 2016 Nov 30;11(11):e0167140 [27902760.001]
  • [Cites] Lancet. 2013 Feb 16;381(9866):575-84 [23410607.001]
  • [Cites] Am J Clin Nutr. 2005 Mar;81(3):714-21 [15755843.001]
  • [Cites] Public Health Nutr. 2006 Dec;9(8):996-1000 [17125562.001]
  • [Cites] Am J Clin Nutr. 2011 Feb;93(2):413-21 [21068343.001]
  • [Cites] Glob Health Action. 2009 Jun 19;2:null [20027273.001]
  • [Cites] BMC Public Health. 2013 Jan 14;13:35 [23316727.001]
  • [Cites] PLoS One. 2014 Nov 26;9(11):e113547 [25426942.001]
  • [Cites] Obes Res Clin Pract. 2015 Jan-Feb;9(1):75-86 [24925607.001]
  • [Cites] Obesity (Silver Spring). 2007 Nov;15(11):2797-808 [18070771.001]
  • [Cites] Lancet Diabetes Endocrinol. 2017 Jan;5(1):53-64 [27743978.001]
  • [Cites] J Epidemiol Community Health. 2007 Sep;61(9):802-9 [17699536.001]
  • [Cites] Lancet. 2014 Aug 30;384(9945):766-81 [24880830.001]
  • [Cites] Int J Obes (Lond). 2008 Sep;32(9):1431-7 [18607383.001]
  • [Cites] BMC Obes. 2016 Mar 01;3:13 [26962459.001]
  • [Cites] Diabetes Care. 2012 Apr;35(4):780-6 [22357187.001]
  • [Cites] Lancet Diabetes Endocrinol. 2016 Dec;4(12 ):1025-1036 [27743975.001]
  • [Cites] Geburtshilfe Frauenheilkd. 2014 Jul;74(7):639-645 [25100878.001]
  • [Cites] Lancet Diabetes Endocrinol. 2016 Dec;4(12 ):966-967 [27743979.001]
  • [Cites] Am J Clin Nutr. 2009 Aug;90(2):369-76 [19515733.001]
  • [Cites] Soc Sci Med. 2004 Oct;59(7):1505-15 [15246178.001]
  • [Cites] Int J Epidemiol. 2007 Apr;36(2):449-57 [17242024.001]
  • (PMID = 28753680.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Bushnell GA, Stürmer T, Gaynes BN, Pate V, Miller M: Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014. JAMA Psychiatry; 2017 Jul 01;74(7):747-755
MedlinePlus Health Information. consumer health - Antidepressants.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Simultaneous Antidepressant and Benzodiazepine New Use and Subsequent Long-term Benzodiazepine Use in Adults With Depression, United States, 2001-2014.
  • Design, Setting, and Participants: This cohort study using a US commercial claims database included commercially insured adults (aged 18-64 years) from January 1, 2001, through December 31, 2014, with a recent depression diagnosis who began antidepressant therapy but had not used antidepressants or benzodiazepines in the prior year.
  • Results: Of the 765 130 adults (median age, 39 years; interquartile range, 29-49 years; 507 451 women [66.3%]) who initiated antidepressant treatment, 81 020 (10.6%) also initiated benzodiazepine treatment.
  • The mean annual increase in the proportion simultaneously starting use of both agents from 2001 to 2014 was 0.49% (95% CI, 0.47%-0.51%), increasing from 6.1% (95% CI, 5.5%-6.6%) in 2001 to 12.5% (95% CI, 12.3%-12.7%) in 2012 and stabilizing through 2014 (11.3%; 95% CI, 11.1%-11.5%).

  • Genetic Alliance. consumer health - Depression.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cochrane Database Syst Rev. 2001;(2):CD001026 [11405972.001]
  • [Cites] Ann Pharmacother. 2012 Apr;46(4):503-12 [22454448.001]
  • [Cites] Arch Gen Psychiatry. 1998 Dec;55(12):1128-32 [9862557.001]
  • [Cites] Age Ageing. 2010 Jul;39(4):488-94 [20511245.001]
  • [Cites] BMC Psychiatry. 2009 Jun 16;9:38 [19531229.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2009 Jan;18(1):7-15 [18980206.001]
  • [Cites] JAMA. 2016 May 24-31;315(20):2230-2 [27218634.001]
  • [Cites] Osteoporos Int. 2006;17(6):807-16 [16520889.001]
  • [Cites] BMJ. 2015 Jun 10;350:h2698 [26063215.001]
  • [Cites] Int J Drug Policy. 2014 May;25(3):569-74 [24412006.001]
  • [Cites] Arch Gen Psychiatry. 2005 Jun;62(6):617-27 [15939839.001]
  • [Cites] Addiction. 2011 Dec;106(12 ):2086-109 [21714826.001]
  • [Cites] Am J Epidemiol. 2004 Apr 1;159(7):702-6 [15033648.001]
  • [Cites] NCHS Data Brief. 2014 Sep;(166):1-8 [25228059.001]
  • [Cites] JAMA. 2013 Feb 20;309(7):657-9 [23423407.001]
  • [Cites] Am J Psychiatry. 1991 Feb;148(2):151-2 [1987812.001]
  • [Cites] Am J Epidemiol. 2013 Feb 15;177(4):292-8 [23371353.001]
  • [Cites] Int Rev Psychiatry. 2005 Jun;17(3):189-97 [16194790.001]
  • [Cites] J Subst Abuse Treat. 1991;8(1-2):53-9 [1675692.001]
  • [Cites] Ann Clin Psychiatry. 2008 Jul-Sep;20(3):157-69 [18633742.001]
  • [Cites] J Affect Disord. 2008 Sep;110(1-2):84-93 [18329721.001]
  • [Cites] J Clin Psychopharmacol. 2011 Jun;31(3):360-4 [21508865.001]
  • [Cites] J Affect Disord. 2002 Aug;70(3):251-9 [12128237.001]
  • [Cites] Am J Public Health. 2016 Apr;106(4):686-8 [26890165.001]
  • [Cites] Drug Alcohol Depend. 2012 Sep 1;125(1-2):8-18 [22857878.001]
  • [Cites] Drug Saf. 2007;30(2):171-84 [17253881.001]
  • [Cites] Am J Public Health. 2016 Nov;106(11):2019-2025 [27631754.001]
  • [Cites] J Clin Psychopharmacol. 2008 Aug;28(4):384-91 [18626264.001]
  • [Cites] J Clin Psychiatry. 2002 Mar;63(3):187-93 [11926716.001]
  • [Cites] J Clin Epidemiol. 2002 Oct;55(10):1049-53 [12464383.001]
  • [Cites] J Clin Psychiatry. 2010;71 Suppl E1:e04 [20371031.001]
  • [Cites] JAMA Psychiatry. 2015 Feb;72(2):136-42 [25517224.001]
  • [Cites] J Psychopharmacol. 2013 Nov;27(11):967-71 [24067791.001]
  • [Cites] Lancet. 1998 Oct 24;352(9137):1331-6 [9802269.001]
  • [Cites] Eur Psychiatry. 2015 Nov;30(8):1037-47 [26545257.001]
  • [Cites] BMC Psychiatry. 2013 Sep 23;13:231 [24053713.001]
  • [Cites] Gen Hosp Psychiatry. 2013 May-Jun;35(3):279-85 [23415578.001]
  • (PMID = 28593281.001).
  • [ISSN] 2168-6238
  • [Journal-full-title] JAMA psychiatry
  • [ISO-abbreviation] JAMA Psychiatry
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antidepressive Agents; 12794-10-4 / Benzodiazepines
  •  go-up   go-down


8. Wang XB, Hong LC, Wei YZ, Fu X, Bao XQ, Zhang J, Hu G, Wu SH, Cheng JQ: [Spectrum and case fatality of inpatients with malignant tumors from 1995 to 2014 in Shenzhen city]. Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jun 10;38(6):784-788
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Spectrum and case fatality of inpatients with malignant tumors from 1995 to 2014 in Shenzhen city].
  • <b>Methods:</b> All the hospitalized malignant tumor patients including deaths, were monitored from 1995 to 2014 in Shenzhen, and data was analyzed by SPSS 20.0 software.
  • <b>Results:</b> There were 160 988 inpatients of malignant tumors between 1995 and 2014 in Shenzhen.
  • The top three hospitalized tumors were lung (13.64<i>%</i>), liver (11.13<i>%</i>) and breast (7.86<i>%</i>) cancers.
  • Numbers of the malignant tumor inpatients had been rapidly increasing during the past 20 years, 12.3 times in 2014 higher than in 1995.
  • The total number of deaths due to malignant tumors was 19 460.
  • Deaths of the top three malignant tumors were lung (24.40<i>%</i>), liver (19.84<i>%</i>) and colorectal (8.63<i>%</i>) cancers and the number of deaths was increasing, 12.5 times higher in 2014 than in 1995.
  • The APC of case fatality rate during 2003-2014 was -3.4<i>%</i>(95<i>%CI</i>: -7.6<i>%</i>-1.1<i>%</i>), but the decreasing trend (<i>t</i>=-1.63, <i>P</i>>0.05) was not statistically significant.
  • The number of male patients was significantly exceeding the females (<i>χ</i>(2)=41.691, <i>P</i><0.01), with sex ratio as 1.65∶1.
  • From age 35 and on, the number of deaths due to malignant tumors increased significantly, with the peak after 60 years of age.
  • <b>Conclusions:</b> The number of malignant tumor inpatients had an annual increase as well as the case fatality rate.
  • <b>目的:</b> 通过对1995-2014年深圳市住院恶性肿瘤病例进行疾病谱及病死率的分析,为本地区恶性肿瘤防治工作提供科学依据。 <b>方法:</b> 对1995-2014年深圳市恶性肿瘤住院及死亡情况进行监测,并采用SPSS 20.0软件对数据进行统计学分析。 <b>结果:</b> 1995-2014年深圳市共报告因恶性肿瘤住院病例160 988例,住院恶性肿瘤前三位依次为肺癌(13.64<i>%</i>)、肝癌(11.13<i>%</i>)、乳腺癌(7.86<i>%</i>)。20年间恶性肿瘤住院人数呈快速增长态势,2014年恶性肿瘤住院病例数是1995年的12.3倍。恶性肿瘤死亡总数19 460例,恶性肿瘤死亡前三位依次为肺癌(24.40<i>%</i>)、肝癌(19.84<i>%</i>)、结肠直肠癌(8.63<i>%</i>),20年间死亡人数也呈增长趋势,2014年死亡数是1995年的12.5倍。恶性肿瘤总病死率为12.09<i>%</i>。1995-2003年深圳市恶性肿瘤病死率年度变化百分比(APC)为9.7<i>%</i>(95<i>%CI</i>:2.0<i>%</i>~18.0<i>%</i>),呈上升趋势(<i>t</i>=2.72,<i>P</i><0.05),2003-2014年深圳市恶性肿瘤病死率APC=-3.4<i>%</i>(95<i>%CI</i>:-7.6<i>%</i>~1.1<i>%</i>),下降趋势无统计学意义(<i>t</i>=-1.63,<i>P</i>>0.05)。住院恶性肿瘤病死率前三位依次为肺癌(21.62<i>%</i>)、肝癌(21.39<i>%</i>)、食道癌(16.50<i>%</i>)。20年间白血病和肝癌病死率有所下降,肺癌、食道癌、胃癌、乳腺癌、结肠直肠癌及鼻咽癌病死率均有所增加。男性病死人数明显多于女性(<i>χ</i>(2)=41.691,<i>P</i><0.01),男∶女为1.65∶1。从35岁开始恶性肿瘤死亡人数显著增高,60岁后达到高峰。 <b>结论:</b> 恶性肿瘤住院及死亡病例逐年增加,病死率呈上升趋势,肺癌、肝癌恶性肿瘤死因位居前列,恶性肿瘤死亡集中在中老年人群。因此,应加强对肺癌、肝癌等重点癌种的防治工作。.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28647983.001).
  • [ISSN] 0254-6450
  • [Journal-full-title] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
  • [ISO-abbreviation] Zhonghua Liu Xing Bing Xue Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Keywords] NOTNLM ; Case fatality rate / Disease spectrum / Hospitalization / Malignancy
  •  go-up   go-down


9. Ye X, Kato K, Wong LY, Jia T, Kalathil A, Latremouille J, Calafat AM: Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014. Int J Hyg Environ Health; 2018 Jan;221(1):9-16

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
  • National Health and Nutrition Examination Survey (NHANES) participants 12 years of age and older since 1999-2000, but PFAS data using NHANES individual samples among children younger than 12 years do not exist.
  • To obtain the first nationally representative PFAS exposure data in U.S. children, we quantified serum concentrations of 14 PFAS including perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA), in a nationally representative subsample of 639 3-11year old participants in NHANES 2013-2014.
  • We calculated geometric mean concentrations, determined weighted Pearson correlations, and used linear regression to evaluate associations of sex, age (3-5 vs 6-11 years), race/ethnicity (Hispanic vs non-Hispanic), household income, and body mass index with concentrations of PFAS detected in more than 60% of participants.
  • We detected PFOS, PFOA, PFHxS, and PFNA in all children at concentrations similar to those of NHANES 2013-2014 adolescents and adults, suggesting prevalent exposure to these PFAS or their precursors among U.S.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier GmbH.
  • [Cites] Chemosphere. 2013 May;91(6):802-8 [23473698.001]
  • [Cites] Environ Health Perspect. 2009 Dec;117(12):1873-82 [20049206.001]
  • [Cites] Environ Health Perspect. 2014 Feb;122(2):187-92 [24280536.001]
  • [Cites] Environ Health Perspect. 2012 May;120(5):752-7 [22271837.001]
  • [Cites] J Expo Sci Environ Epidemiol. 2010 Nov;20(7):589-97 [19865074.001]
  • [Cites] Environ Sci Technol. 2009 Apr 1;43(7):2641-7 [19452929.001]
  • [Cites] Environ Health Perspect. 2007 Nov;115(11):1596-602 [18007991.001]
  • [Cites] Public Health Rep. 2014 Nov-Dec;129(6):482-5 [25364048.001]
  • [Cites] Environ Health Perspect. 2007 Nov;115(11):1677-82 [18008003.001]
  • [Cites] Environ Sci Technol. 2009 Jun 1;43(11):4194-9 [19569351.001]
  • [Cites] Toxicol Sci. 2007 Oct;99(2):366-94 [17519394.001]
  • [Cites] Environ Sci Technol. 2013;47(23 ):13266-75 [24187954.001]
  • [Cites] Environ Res. 2010 Nov;110(8):773-7 [20800832.001]
  • [Cites] Chemosphere. 2011 May;83(10 ):1320-5 [21531441.001]
  • [Cites] Chemosphere. 2015 Jun;129:39-45 [25262531.001]
  • [Cites] Reprod Toxicol. 2009 Jun;27(3-4):231-8 [19049861.001]
  • [Cites] Environ Sci Technol. 2004 Sep 1;38(17 ):4489-95 [15461154.001]
  • [Cites] Environ Sci Technol. 2011 Oct 1;45(19):8160-6 [21534542.001]
  • [Cites] Environ Sci Technol. 2006 Jan 1;40(1):32-44 [16433330.001]
  • [Cites] Environ Int. 2015 Oct;83:176-82 [26159671.001]
  • [Cites] Environ Int. 2013 Feb;52:1-8 [23266910.001]
  • [Cites] Int J Hyg Environ Health. 2012 Feb;215(2):212-5 [22001330.001]
  • [Cites] Environ Health Perspect. 2010 Aug;118(8):1100-8 [20423814.001]
  • [Cites] Environ Health Perspect. 2009 Apr;117(4):660-7 [19440508.001]
  • [Cites] Environ Sci Technol. 2017 Jun 6;51(11):6387-6394 [28482666.001]
  • [Cites] Reprod Toxicol. 2009 Jun;27(3-4):212-30 [19429401.001]
  • [Cites] Environ Health Perspect. 2012 Apr;120(4):590-4 [22182702.001]
  • [Cites] Environ Pollut. 2014 Jan;184:327-34 [24095703.001]
  • [Cites] Environ Sci Technol. 2006 Feb 1;40(3):715-20 [16509308.001]
  • [Cites] Environ Sci Technol Lett. 2016 Oct 11;3(10 ):344-350 [27752509.001]
  • [Cites] Arch Environ Contam Toxicol. 2009 Nov;57(4):631-8 [19685096.001]
  • [Cites] Environ Res. 2012 Jul;116:93-117 [22560884.001]
  • [Cites] Environ Sci Technol. 2010 Jun 1;44(11):4341-7 [20441147.001]
  • [Cites] Int Arch Occup Environ Health. 2007 Feb;80(4):313-9 [16915390.001]
  • [Cites] Environ Sci Technol. 2007 Apr 1;41(7):2237-42 [17438769.001]
  • [Cites] Environ Res. 2016 Jul;148:351-359 [27111244.001]
  • [Cites] Toxicol Appl Pharmacol. 2004 Jul 15;198(2):231-41 [15236955.001]
  • [Cites] Environ Int. 2015 Nov;84:71-81 [26232143.001]
  • [Cites] Environ Res. 2015 Jan;136:264-73 [25460645.001]
  • [Cites] Environ Sci Technol. 2011 Oct 1;45(19):8151-9 [21682250.001]
  • [Cites] Int J Environ Res Public Health. 2013 Feb 07;10 (2):699-711 [23435591.001]
  • [Cites] J Environ Health. 2014 Dec;77(5):14-9 [25619022.001]
  • [Cites] Environ Health Perspect. 2007 Nov;115(11):1670-6 [18008002.001]
  • [Cites] Arch Environ Contam Toxicol. 2012 Jul;63(1):1-12 [22402780.001]
  • [Cites] Environ Health Perspect. 2011 Jan;119(1):92-7 [20920951.001]
  • [Cites] Environ Sci Technol. 2017 May 2;51(9):5193-5204 [28325044.001]
  • [Cites] Environ Sci Technol. 2014 Aug 19;48(16):9600-8 [25026485.001]
  • [Cites] Chemosphere. 2016 Feb;144:1631-8 [26517392.001]
  • [Cites] Toxicol Lett. 2014 Oct 15;230(2):263-70 [24503008.001]
  • [Cites] Chemosphere. 2013 Feb;90(5):1603-9 [22990023.001]
  • [Cites] J Immunotoxicol. 2013 Oct-Dec;10 (4):373-9 [23350954.001]
  • [Cites] Crit Rev Toxicol. 2004 Jul-Aug;34(4):351-84 [15328768.001]
  • [Cites] Int J Hyg Environ Health. 2010 Jun;213(3):224-32 [20556880.001]
  • [Cites] Environ Sci Technol. 2009 Mar 15;43(6):2131-6 [19368225.001]
  • [Cites] Environ Toxicol Chem. 2014 Feb;33(2):243-67 [24114778.001]
  • [Cites] Environ Health Perspect. 2011 Oct;119(10):1466-71 [21665566.001]
  • [Cites] Environ Health Perspect. 2008 May;116(5):651-7 [18470314.001]
  • [Cites] Toxicol Appl Pharmacol. 2012 Jan 15;258(2):248-55 [22119708.001]
  • [Cites] Environ Sci Technol. 2006 Jun 15;40(12 ):3742-8 [16830536.001]
  • [Cites] Environ Pollut. 2014 Sep;192:171-8 [24952613.001]
  • [Cites] Environ Sci Technol. 2017 Apr 18;51(8):4482-4493 [28323424.001]
  • [Cites] Paediatr Perinat Epidemiol. 2014 Mar;28(2):146-56 [24320613.001]
  • [Cites] Am J Epidemiol. 2008 Jul 1;168(1):66-72 [18460444.001]
  • (PMID = 28993126.001).
  • [ISSN] 1618-131X
  • [Journal-full-title] International journal of hygiene and environmental health
  • [ISO-abbreviation] Int J Hyg Environ Health
  • [Language] eng
  • [Grant] United States / Intramural CDC HHS / / CC999999
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Biomonitoring / Exposure / NHANES / PFAS
  •  go-up   go-down


10. Zhang P, Zhang J: [Surveillance on other infectious diarrheal diseases in China from 2014 to 2015]. Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr 10;38(4):424-430
MedlinePlus Health Information. consumer health - Infectious Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surveillance on other infectious diarrheal diseases in China from 2014 to 2015].
  • <b>Objective:</b> To analyze the current situation on infectious diarrhea other than cholera, dysentery, typhoid and paratyphoid (hereinafter referred to as Other Infectious Diarrheal Diseases) under the current monitoring program in China from 2014 to 2015, to provide evidence for developing strategies related to the control of these diseases.
  • <b>Results:</b> In 2014, a total of 867 545 infectious diarrhea cases were reported, with the incidence rate as 64.0/100 000.
  • While in 2015, a total of 937 616 infectious diarrhea cases were reported, and the incidence rate was 68.8/100 000.
  • Cases involved in all the age groups, with 53.7<i>%</i> (968 984/1 805 161) of the total reported cases below 5 years of age.
  • Laboratory-confirmed cases accounted for 9.5<i>%</i> (82 285/867 545) of the total and 9.3<i>%</i>(86 975/937 616) of the cases reported in 2014 and 2015 respectively.

  • MedlinePlus Health Information. consumer health - Diarrhea.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28468056.001).
  • [ISSN] 0254-6450
  • [Journal-full-title] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
  • [ISO-abbreviation] Zhonghua Liu Xing Bing Xue Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Keywords] NOTNLM ; Etiology / Infectious diarrhea / Surveillance
  •  go-up   go-down